Krankenhaus der Barmherzigen Brüder
About Krankenhaus der Barmherzigen Brüder
"Medizinische und therapeutische Abteilungen und Pflege richten sich nach aktuellen Erkenntnissen. Achtung vor dem Leben, ganzheitliche Zuwendung gegenüber Patienten u. Angehörigen prägen unsere Klinik"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
7
Abbott Medical Devices
5
Boston Scientific Corporation
5
Elixir Medical Corporation
4
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
2
Daiichi Sankyo, Inc.
2
Ipsen
2
Merck Sharp & Dohme LLC
2
Vascular Graft Solutions Ltd.
2
Weill Medical College of Cornell University
2
Clinical Trials at Krankenhaus der Barmherzigen Brüder
During the past decade, Krankenhaus der Barmherzigen Brüder conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on
average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries
2005-03-01
2012-05-01
Unknown status
1,800
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
2006-07-01
2016-06-01
Completed
1,256
Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease
2008-08-01
2010-09-01
Unknown status
258
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder" #1 sponsor was "University of Ulm" with 7 trials, followed by "Abbott Medical Devices" with 5 trials
sponsored, "Boston Scientific Corporation" with 5 trials sponsored, "Elixir Medical Corporation" with 4 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group"
with 4 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 39 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder"
#1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were
collaborators in the rest 36 trials.
Clinical Trials Conditions at Krankenhaus der Barmherzigen Brüder
According to Clinical.Site data, the most researched conditions in "Krankenhaus der Barmherzigen Brüder" are
"Coronary Artery Disease" (12 trials), "Acute Myeloid Leukemia (AML)" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Aortic Valve Stenosis" (3 trials) and "Coronary Artery Stenosis" (3 trials). Many other conditions were trialed in "Krankenhaus der Barmherzigen Brüder" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus der Barmherzigen Brüder
Most popular intervention types in "Krankenhaus der Barmherzigen Brüder" are "Drug" (25 trials), "Device" (24 trials), "Biological" (7 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cytarabine" (5 trials), "Placebo" (5 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus der Barmherzigen Brüder
The vast majority of trials in "Krankenhaus der Barmherzigen Brüder" are
60 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Krankenhaus der Barmherzigen Brüder
Currently, there are 18 active trials in "Krankenhaus der Barmherzigen Brüder".
1 are not yet recruiting,
10 are recruiting,
6 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 35 completed trials in Krankenhaus der Barmherzigen Brüder,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus der Barmherzigen Brüder, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 18 trials that are defined as “Not Applicable".
Departments of Krankenhaus der Barmherzigen Brüder
Krankenhaus der Barmherzigen Brüder has several departments that took part in Clinical trials: "Krankenhaus der Barmherzigen Brüder Trier; Innere Medizin I, Hämatologie / Internistische Onkologie" - 3 trials, "Diabetologische Schwerpunktpraxis" - 2 trials
Departments List